Cargando…
Identification of an aprotinin antiviral domain
Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the forme...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130179/ https://www.ncbi.nlm.nih.gov/pubmed/7514546 http://dx.doi.org/10.1016/0014-5793(94)00396-3 |
_version_ | 1783516952147263488 |
---|---|
author | Pellegrini, Antonio Thomas, Ursula Franchini, Marco Stöckli, Martina Klauser, Stefan Hunziker, Peter von Fellenberg, Roland |
author_facet | Pellegrini, Antonio Thomas, Ursula Franchini, Marco Stöckli, Martina Klauser, Stefan Hunziker, Peter von Fellenberg, Roland |
author_sort | Pellegrini, Antonio |
collection | PubMed |
description | Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y-F-Y-N-A-K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187]. |
format | Online Article Text |
id | pubmed-7130179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71301792020-04-08 Identification of an aprotinin antiviral domain Pellegrini, Antonio Thomas, Ursula Franchini, Marco Stöckli, Martina Klauser, Stefan Hunziker, Peter von Fellenberg, Roland FEBS Lett Article Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y-F-Y-N-A-K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187]. Published by Elsevier B.V. 1994-05-16 2001-12-07 /pmc/articles/PMC7130179/ /pubmed/7514546 http://dx.doi.org/10.1016/0014-5793(94)00396-3 Text en Copyright © 1994 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pellegrini, Antonio Thomas, Ursula Franchini, Marco Stöckli, Martina Klauser, Stefan Hunziker, Peter von Fellenberg, Roland Identification of an aprotinin antiviral domain |
title | Identification of an aprotinin antiviral domain |
title_full | Identification of an aprotinin antiviral domain |
title_fullStr | Identification of an aprotinin antiviral domain |
title_full_unstemmed | Identification of an aprotinin antiviral domain |
title_short | Identification of an aprotinin antiviral domain |
title_sort | identification of an aprotinin antiviral domain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130179/ https://www.ncbi.nlm.nih.gov/pubmed/7514546 http://dx.doi.org/10.1016/0014-5793(94)00396-3 |
work_keys_str_mv | AT pellegriniantonio identificationofanaprotininantiviraldomain AT thomasursula identificationofanaprotininantiviraldomain AT franchinimarco identificationofanaprotininantiviraldomain AT stocklimartina identificationofanaprotininantiviraldomain AT klauserstefan identificationofanaprotininantiviraldomain AT hunzikerpeter identificationofanaprotininantiviraldomain AT vonfellenbergroland identificationofanaprotininantiviraldomain |